Zuzana Tothova, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromosomal Proteins, Non-Histone | 4 | 2022 | 735 | 1.250 |
Why?
|
| Myeloproliferative Disorders | 5 | 2021 | 606 | 1.170 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2024 | 1352 | 1.060 |
Why?
|
| Cell Cycle Proteins | 6 | 2022 | 3463 | 0.850 |
Why?
|
| Leukemia, Myeloid | 2 | 2021 | 707 | 0.710 |
Why?
|
| Hematopoietic Stem Cells | 8 | 2021 | 3389 | 0.680 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2024 | 3524 | 0.660 |
Why?
|
| Forkhead Transcription Factors | 7 | 2011 | 1613 | 0.650 |
Why?
|
| DNA Repair | 3 | 2024 | 2045 | 0.520 |
Why?
|
| Mutation | 8 | 2024 | 29777 | 0.510 |
Why?
|
| Hematopoiesis | 3 | 2017 | 2073 | 0.480 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2012 | 84 | 0.400 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2014 | 260 | 0.360 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 1832 | 0.350 |
Why?
|
| Neoplastic Stem Cells | 4 | 2016 | 1376 | 0.350 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3706 | 0.330 |
Why?
|
| Hematopoietic System | 1 | 2007 | 109 | 0.300 |
Why?
|
| Radiation Tolerance | 1 | 2009 | 486 | 0.280 |
Why?
|
| Blood Cells | 1 | 2007 | 310 | 0.250 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2012 | 1660 | 0.240 |
Why?
|
| DNA Damage | 3 | 2024 | 2429 | 0.240 |
Why?
|
| Genome, Human | 1 | 2017 | 4418 | 0.240 |
Why?
|
| Reactive Oxygen Species | 2 | 2009 | 2077 | 0.240 |
Why?
|
| Cell Lineage | 4 | 2017 | 2506 | 0.210 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 1684 | 0.200 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2021 | 45 | 0.200 |
Why?
|
| Leukemia | 3 | 2017 | 1509 | 0.200 |
Why?
|
| Chromatin | 3 | 2021 | 2931 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2017 | 5532 | 0.200 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2021 | 189 | 0.200 |
Why?
|
| Critical Care | 1 | 2014 | 2647 | 0.190 |
Why?
|
| Models, Biological | 1 | 2017 | 9582 | 0.190 |
Why?
|
| Epigenesis, Genetic | 3 | 2021 | 3645 | 0.190 |
Why?
|
| U937 Cells | 1 | 2021 | 268 | 0.190 |
Why?
|
| Wills | 1 | 2019 | 14 | 0.170 |
Why?
|
| Cell Differentiation | 7 | 2021 | 11478 | 0.170 |
Why?
|
| K562 Cells | 1 | 2021 | 635 | 0.170 |
Why?
|
| RNA Splicing | 1 | 2024 | 907 | 0.170 |
Why?
|
| Phthalazines | 1 | 2021 | 359 | 0.160 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2021 | 651 | 0.150 |
Why?
|
| Antigens, CD34 | 2 | 2017 | 658 | 0.150 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 1862 | 0.150 |
Why?
|
| Zygote | 1 | 2017 | 115 | 0.150 |
Why?
|
| Mice | 17 | 2021 | 81154 | 0.140 |
Why?
|
| Histone Demethylases | 1 | 2019 | 321 | 0.140 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1876 | 0.140 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 9731 | 0.140 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 87 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3082 | 0.130 |
Why?
|
| ARNTL Transcription Factors | 1 | 2016 | 98 | 0.130 |
Why?
|
| Mice, SCID | 1 | 2021 | 2718 | 0.130 |
Why?
|
| Calreticulin | 1 | 2016 | 98 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2022 | 8430 | 0.130 |
Why?
|
| Phosphoproteins | 1 | 2024 | 2440 | 0.120 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2016 | 157 | 0.120 |
Why?
|
| Genes, ras | 1 | 2017 | 690 | 0.120 |
Why?
|
| Clone Cells | 1 | 2017 | 1692 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 474 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3547 | 0.110 |
Why?
|
| Animals | 18 | 2021 | 168660 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 1900 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 2942 | 0.100 |
Why?
|
| ras Proteins | 1 | 2017 | 1059 | 0.100 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 135 | 0.100 |
Why?
|
| Transcription Factors | 4 | 2024 | 12209 | 0.100 |
Why?
|
| Gene Targeting | 1 | 2014 | 879 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 729 | 0.100 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 16674 | 0.090 |
Why?
|
| Genetic Engineering | 1 | 2016 | 950 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 21824 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 18027 | 0.090 |
Why?
|
| Gene Fusion | 1 | 2012 | 371 | 0.080 |
Why?
|
| STAT Transcription Factors | 2 | 2022 | 182 | 0.080 |
Why?
|
| Radiation, Ionizing | 1 | 2009 | 258 | 0.080 |
Why?
|
| Janus Kinases | 2 | 2022 | 244 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2011 | 1142 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2014 | 1537 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2017 | 5445 | 0.080 |
Why?
|
| Lymphoma, T-Cell | 2 | 2007 | 299 | 0.070 |
Why?
|
| Humans | 19 | 2024 | 743811 | 0.070 |
Why?
|
| Retinol-Binding Proteins | 1 | 2007 | 65 | 0.070 |
Why?
|
| Megakaryocytes | 1 | 2011 | 545 | 0.070 |
Why?
|
| Salvage Therapy | 1 | 2014 | 1275 | 0.070 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2007 | 97 | 0.070 |
Why?
|
| Receptors, Notch | 1 | 2011 | 739 | 0.070 |
Why?
|
| Multipotent Stem Cells | 1 | 2007 | 186 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2013 | 1811 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 1097 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 5854 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 2504 | 0.060 |
Why?
|
| Genotype | 2 | 2017 | 12944 | 0.060 |
Why?
|
| RNA | 1 | 2014 | 2748 | 0.060 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2007 | 491 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2010 | 2749 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2009 | 10477 | 0.050 |
Why?
|
| Myeloid Cells | 1 | 2007 | 808 | 0.050 |
Why?
|
| Neoplasms | 2 | 2022 | 21675 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 20827 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2021 | 14563 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 2110 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4152 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 13691 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2014 | 3679 | 0.050 |
Why?
|
| Erythroid Cells | 1 | 2021 | 239 | 0.050 |
Why?
|
| Telomerase | 1 | 2005 | 731 | 0.050 |
Why?
|
| Cell Survival | 2 | 2007 | 5881 | 0.040 |
Why?
|
| Genomics | 1 | 2016 | 5714 | 0.040 |
Why?
|
| Homeostasis | 2 | 2007 | 3337 | 0.040 |
Why?
|
| Signal Transduction | 6 | 2016 | 23398 | 0.040 |
Why?
|
| Antioxidants | 1 | 2007 | 1658 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2007 | 2615 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2007 | 2963 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 12066 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12954 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17439 | 0.040 |
Why?
|
| Cell Line | 3 | 2022 | 15993 | 0.040 |
Why?
|
| Structure Collapse | 1 | 2016 | 4 | 0.040 |
Why?
|
| Histones | 1 | 2007 | 2598 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 2850 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2007 | 2951 | 0.030 |
Why?
|
| Apoptosis | 2 | 2011 | 9718 | 0.030 |
Why?
|
| Kinetics | 1 | 2022 | 6476 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 2453 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2011 | 19232 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2021 | 1295 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2016 | 399 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3482 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2004 | 1377 | 0.030 |
Why?
|
| Lovastatin | 1 | 2013 | 120 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2022 | 2500 | 0.030 |
Why?
|
| Gene Library | 1 | 2016 | 1074 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 807 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7719 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2022 | 4221 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2021 | 2969 | 0.030 |
Why?
|
| Prognosis | 1 | 2013 | 29052 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 2014 | 289 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5973 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2011 | 118 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 9239 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 9648 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2016 | 1606 | 0.020 |
Why?
|
| Thrombopoiesis | 1 | 2011 | 153 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 452 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 2764 | 0.020 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2007 | 13 | 0.020 |
Why?
|
| Genome | 1 | 2016 | 1806 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 2007 | 246 | 0.020 |
Why?
|
| RNA Interference | 1 | 2016 | 2890 | 0.020 |
Why?
|
| Spodoptera | 1 | 2007 | 153 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3504 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 63042 | 0.020 |
Why?
|
| Female | 3 | 2021 | 380020 | 0.020 |
Why?
|
| Fibroblasts | 2 | 2007 | 4162 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 676 | 0.020 |
Why?
|
| Phenotype | 2 | 2016 | 16361 | 0.020 |
Why?
|
| Base Sequence | 1 | 2016 | 12798 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 2620 | 0.020 |
Why?
|
| Male | 2 | 2021 | 349776 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 1826 | 0.010 |
Why?
|
| Methylation | 1 | 2007 | 1104 | 0.010 |
Why?
|
| Protein Binding | 1 | 2016 | 9377 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 2509 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 895 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2007 | 1723 | 0.010 |
Why?
|
| Solubility | 1 | 2005 | 1088 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2010 | 3000 | 0.010 |
Why?
|
| Hemangioma | 1 | 2007 | 738 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 2438 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1702 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3847 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 1351 | 0.010 |
Why?
|
| Telomere | 1 | 2005 | 910 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2649 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3255 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 6380 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3917 | 0.010 |
Why?
|
| Lymphoma | 1 | 2007 | 1875 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4749 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2007 | 1709 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2419 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 2938 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 6539 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 4568 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 4463 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 7324 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 12786 | 0.010 |
Why?
|